H-SPAN Summit D.C. 2026 | Louise Hecker - FibroNox

Psychedelics research has focused almost entirely on psychiatric outcomes. This presentation asks a different question: whether psilocybin produces effects at the cellular level that are relevant to aging itself. It covers the preclinical evidence to date, including work in aged cells and animal models, the mechanisms proposed to explain those results, and what a serious clinical research agenda would need to look like.